Company profile
Abeona Therapeutics company profile
Abeona Therapeutics is developing gene therapy-based potential cures for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and Type B. Its multi-platform expertise across the manufacture, delivery, development, and discovery of the novel gene and cell therapies has it uniquely positioned for success. Underpinning the Company’s robust pipeline is its fully-operational manufacturing facility producing therapies and vectors for preclinical and clinical studies. Abeona is also developing the AIM Vector Platform: 100+ next-generation AAV capsids for delivering gene therapies targeting a wide range of organs and multiple routes of delivery.
Business identity
- Contact email
- [email protected]
- Phone number
- (216)287-5408
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00101-00250 employees
- Revenue range
- $1K+
- Founded
- 1989-01-01
Headquarters
- Headquarters
- Troy, New Hampshire, United States
- Country code
- US
- Continent
- North America